CREB3L1 silenced by CREB3L1 promoter hypermethylation resulted in a more aggressive phenotype in BLCA, and no significant correlation between CREB3L1 and tumor stage was detected in this study (Rose et al., 2014). This evidence concerns the gene CREB3L1 and bladder transitional cell carcinoma.